About the Preventive Medicine and Screening Session
Preventive medicine promotes early action to reduce disease risk, detect health conditions promptly and improve long-term outcomes. This session explores population screening, health assessments, risk prediction, early diagnosis, preventive services and evidence-based interventions delivered through clinical and community settings.
Abstract Scope and Participation
Abstracts may cover screening programs, diagnostic pathways, preventive check-ups, risk assessment tools, early detection technologies and evaluations of preventive interventions. Physicians, nurses, researchers, allied health professionals, public-health teams, program coordinators and policymakers are invited to share research, practice models and service innovations.
Topics Covered in Preventive Medicine and Screening
Topic 01
Population-based screening programs
Topic 02
Early diagnosis and risk assessment
Topic 03
Preventive health examinations
Topic 04
Screening guidelines and implementation
Topic 05
Diagnostic pathways and referral systems
Topic 06
Evaluation of preventive healthcare services
Featured Speakers — Preventive Medicine and Screening 2027
Silvana Maria Trujillo Cardenas
University Foundation of Health Sciences
The future of primary care: Family medicine, clinical screening, and health equity
Recent Research Presented at Preventive Medicine and Screening Sessions
Non-communicable disease risk assessment among adults aged ≥30 years in an urban field practice area using the community-based assessment checklist: A cross-sectional study
Background: Non-Communicable Diseases (NCDs) are a public health concern in India, driven by behavioural and biological risk factors. Community-based risk assessment facilitates early identification…
A comparative study of the slippage distance in static and dynamic lumbar radiographs for spondylolisthesis patients at the MTRH spine clinic, Eldoret, Kenya
Background: Low back pain is a common presenting complaint for patients seeking healthcare, the age standard prevalence of lower back pain was around 8.20% in 1990 and declined slightly to about 7.5%…
The future of primary care: Family medicine, clinical screening, and health equity
Introduction: Global health systems face a growing burden of chronic non-communicable diseases and persistent gaps in equitable access to medical services. Against this backdrop, optimizing Primary…
Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation
Chemical carcinogens classified by the International Agency for Research on Cancer (IARC) as Group 1 very probably contribute to cancer occurrence in over 13.5 million people and death from cancer in…
Gaps in breast cancer awareness and screening practices among women in Lucknow, Uttar Pradesh
Breast cancer remains the most common malignancy among women globally, yet awareness and early screening practices remain low in low- and middle-income countries like India. To assess and compare…
Development and validation of a diagnostic nomogram to predict high altitude pulmonary edema
Background: High altitude pulmonary edema (HAPE) are one of the clinical manifestations of acute mountain sickness (AMS). A fatal risk of HAPE has been contribute to a lack of prediction and delayed…
Related Scientific Sessions at IPHC 2027
Why Attend the Preventive Medicine and Screening Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Preventive Medicine and Screening work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Preventive Medicine and Screening research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Preventive Medicine and Screening track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Preventive Medicine and Screening Conference 2027 — FAQs
What is the Preventive Medicine and Screening track at IPHC 2027?
The Preventive Medicine and Screening track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Preventive Medicine and Screening. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Preventive Medicine and Screening sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Preventive Medicine and Screening are all welcome — whether presenting or attending.
Can I present my research in the Preventive Medicine and Screening track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Preventive Medicine and Screening sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Preventive Medicine and Screening track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.